Telix Pharmaceuticals Ltd Files 2024 Annual Report
Ticker: TLPPF · Form: 20-F · Filed: Feb 24, 2025 · CIK: 2007191
| Field | Detail |
|---|---|
| Company | Telix Pharmaceuticals Ltd (TLPPF) |
| Form Type | 20-F |
| Filed Date | Feb 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, financials, pharmaceuticals
TL;DR
Telix Pharma dropped its 2024 20-F, check financials for FY ending Dec 31, 2024.
AI Summary
Telix Pharmaceuticals Ltd filed its 20-F for the fiscal year ending December 31, 2024. The filing details the company's financial performance and business operations, including its incorporation in C3 and its principal executive offices located at 55 Flemington Road, North Melbourne, Australia. Key dates mentioned include the filing date of February 24, 2025, and various reporting periods throughout 2024 and prior years.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Telix Pharmaceuticals' financial health and strategic direction for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Telix is subject to regulatory risks, clinical trial outcomes, and market competition, which are inherent to the industry.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 20-F filing.)
- 2025-02-24 — Filing Date (The date the 20-F was submitted to the SEC.)
Key Players & Entities
- Telix Pharmaceuticals Ltd (company) — Filer of the 20-F report
- 55 Flemington Road, North Melbourne (location) — Business and mailing address
- 2024-12-31 (date) — Fiscal year end
- 2025-02-24 (date) — Filing date
FAQ
What is the primary business of Telix Pharmaceuticals Ltd?
Telix Pharmaceuticals Ltd is in the business of Pharmaceutical Preparations, as indicated by its SIC code [2834].
Where are Telix Pharmaceuticals Ltd's principal executive offices located?
The company's business and mailing address is 55 Flemington Road, North Melbourne, C3, 3051.
What is the fiscal year end for Telix Pharmaceuticals Ltd?
The fiscal year end for Telix Pharmaceuticals Ltd is December 31 (1231).
When was this 20-F filing submitted to the SEC?
This 20-F filing was submitted on February 24, 2025.
What is the SEC file number for Telix Pharmaceuticals Ltd?
The SEC file number for Telix Pharmaceuticals Ltd is 001-42128.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on February 24, 2025 regarding Telix Pharmaceuticals Ltd (TLPPF).